Concepedia

Publication | Closed Access

A Prospective Safety Surveillance Study for Bupropion Sustained-Release in the Treatment of Depression

DOI

179

Citations

0

References

1998

Year

David L. Dunner, Sidney Zisook, Alacia A. Billow, Sharyn R. Batey, Joseph A. Johnston, John A. Ascher
The Journal of Clinical Psychiatry

Abstract

The therapeutic use of bupropion SR at total daily doses up to 300 mg/day in depressed patients without predisposition to seizures is associated with a seizure rate that is well within the range observed with other marketed antidepressants.